Hydroxychloroquine is an inexpensive and easily available drug. However, its demand has risen dramatically ever since it was named as a possible treatment for Covid-19
HCQ is the same drug that US President Donald Trump had sought from India and warned of retaliation if India did not supply the drug
Manufacturers say there is enough stock for local needs
On March 25, India banned the export of hydroxychloroquine, which is used primarily to treat malaria and lupus
Novartis is donating 130 million hydroxychloroquine doses to support efforts against the epidemic, though the European Union has so far said there is no proof it works.
Sensing serious health risks, the government has swung into action. Dispensing of these medicines would get stricter and states have started collecting information on available stock in the market
On private laboratories being allowed to conduct testing for COVID-19, Bhargava said 12 private-lab chains have been registered and have started working after being allowed the testing
Medicine is a therapeutic equivalent of Plaquenil tablets of Concordia Pharma of US